Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Incremented the page software revision from v3.6.5 to v3.6.6, signaling a minor backend or template update for the ClinicalTrials.gov study details page. No visible user-facing content or functionality appears to be altered.
    Difference
    0.1%
    Check dated 2026-08-29T19:13:07.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, signaling a new build of the page. This reflects an internal version update rather than a content change.
    Difference
    0.1%
    Check dated 2026-08-08T18:20:31.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page footer now shows the updated site revision number (v3.6.4), replacing the previous v3.6.3. This indicates a minor platform update that does not modify study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-25T10:00:50.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a minor version update to the page rather than a content change.
    Difference
    0.1%
    Check dated 2026-07-03T21:50:18.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.0 to v3.6.2, indicating a small internal update to the page rendering or templates. No study content or user-visible information was altered.
    Difference
    0.1%
    Check dated 2026-06-27T00:21:43.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study were added, and Hyun Cheol Chung and Yonsei University are now listed as the responsible party; the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    2%
    Check dated 2026-06-12T16:06:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.